Pipeline
Phase III Clinical Trials (updated 2/1/2009)
|
Description
|
Protocol |
IND # |
| A Randomized Phase III Study of Combination Antineoplaston Therapy [Antineoplaston A10 (Atengenal) and AS2-1 (Astugenal)] Plus Radiation Therapy vs. Radiation Therapy Alone in Subjects with Newly Diagnosed, Diffuse, Intrinsic Brain Stem Glioma. |
BRI-BT-50 |
43,742 |
Phase II Clinical Trials (updated 2/1/2009)
|
Description
|
Protocol |
IND # |
|
PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN PATIENTS WITH CARCINOMA OF THE ADRENAL GLAND.
|
BRI-AD-02 |
43,742 |
|
PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADULT PATIENTS WITH ANAPLASTIC ASTROCYTOMA.
|
BRI-BT-08 |
43,742 |
| PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN PATIENTS WITH BRAIN TUMORS. |
BRI-BT-09 |
43,742 |
| PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CHILDREN WITH BRAIN TUMORS. |
BRI-BT-10 |
43,742 |
| PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN CHILDREN WITH LOW GRADE ASTROCYTOMA. |
BRI-BT-13 |
43,742 |
| PHASE II STUDY OF ANTINEOPLASTON A10 AND AS2-1 IN ADULT PATIENTS WITH ANAPLASTIC ASTROCYTOMA. |
BRI-BT-15 |
43,742 |
| PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADULT PATIENTS WITH MIXED GLIOMA. |
BRI-BT-18 |
43,742 |
| PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN ADULT PATIENTS WITH PRIMARY MALIGNANT BRAIN TUMORS. |
BRI-BT-21 |
43,742 |
| PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN CHILDREN WITH PRIMARY MALIGNANT BRAIN TUMORS. |
BRI-BT-22 |
43,742 |
| PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 INFUSIONS IN CHILDREN WITH VISUAL PATHWAY GLIOMA. |
BRI-BT-23 |
43,742 |
|
